RxDoctor Payments Data

Ashlyn Harris, PA

Surgical · New Orleans, LANPI 1609401041

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,442 of the $2,166 with a category attached, or 66.6%. 10 manufacturers reported payments, led by Medical Device Business Services, Inc. at 43.9% of the total. 2025 is the largest year on record at $1,440, more than ten times the $141 reported in 2021.

$2,166in general payments, 2019–2025

Across 24 payments — averaging $90.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$951
  • Si-bone, Inc.$319
  • Amgen$282
  • Johnson & Johnson$183
  • Stryker$159
  • Vertex$120
  • plus $151 from 4 others

What the payments were for

  • Travel & lodging$72333%
  • Food & beverage$1,44267%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,166 in reported general payments places this provider in the 80th percentile of 130 surgical providers in Louisiana.

See all surgical providers in Louisiana

Medicare billing

Part B allowed, 2024
$22,206
Medicare patients
143
Services billed
515

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin174$2,011
Celecoxib47$584
Methylprednisolone55$432
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$391
Tizanidine Hcl39$272
Cyclobenzaprine Hcl33$217
Tramadol Hcl48$196
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen19$173
Methocarbamol17$169
Diclofenac Potassium11$157
Meloxicam90$146
Diazepam14$16

Paid to pharmacies, not to this prescriber.

Other surgical in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →